Insulin glargine is cost-effective in treatment of patients with diabetes type-2 in whom nph insulin does not provide adequate glycaemic control – The case of poland
May 1, 2013, 00:00
10.1016/j.jval.2013.03.824
https://www.valueinhealthjournal.com/article/S1098-3015(13)00895-4/fulltext
Title :
Insulin glargine is cost-effective in treatment of patients with diabetes type-2 in whom nph insulin does not provide adequate glycaemic control – The case of poland
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00895-4&doi=10.1016/j.jval.2013.03.824
First page :
A165
Section Title :
Diabetes/Endocrine Disorders
Open access? :
No
Section Order :
374